Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M. González-Martín A, et al. Among authors: de duenas em, de la haba j, de la pena fa. Curr Cancer Drug Targets. 2016;16(5):415-28. doi: 10.2174/1568009615666150817121731. Curr Cancer Drug Targets. 2016. PMID: 26278712 Review.
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial.
Del Barco S, Colomer R, Calvo L, Tusquets I, Adrover E, Sánchez P, Rifà J, De la Haba J, Virizuela JA. Del Barco S, et al. Among authors: de la haba j. Breast Cancer Res Treat. 2009 Jul;116(2):351-8. doi: 10.1007/s10549-008-0218-8. Epub 2008 Oct 22. Breast Cancer Res Treat. 2009. PMID: 18941891 Clinical Trial.
Neoadjuvant endocrine therapy for breast cancer: past, present and future.
Barnadas A, Gil M, Sánchez-Rovira P, Llombart A, Adrover E, Estevez LG, de la Haba J, Calvo L. Barnadas A, et al. Among authors: de la haba j. Anticancer Drugs. 2008 Apr;19(4):339-47. doi: 10.1097/CAD.0b013e3282f97f75. Anticancer Drugs. 2008. PMID: 18454044 Review.
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Bayo-Calero JL, Mayordomo JI, Sánchez-Rovira P, Pérez-Carrión R, Illaramendi JJ, García-Bueno JM, González-Flores E, Crespo C, Ramos-Vázquez M, García-Palomo A, Ruiz-Borrego M, de la Haba J, Gómez-Bernal A, Yubero-Esteban A. Bayo-Calero JL, et al. Among authors: de la haba j. Clin Breast Cancer. 2008 Jun;8(3):264-8. doi: 10.3816/CBC.2008.n.030. Clin Breast Cancer. 2008. PMID: 18650157 Clinical Trial.
Role of germline variants in the metastasis of breast carcinomas.
Santonja Á, Moya-García AA, Ribelles N, Jiménez-Rodríguez B, Pajares B, Fernández-De Sousa CE, Pérez-Ruiz E, Del Monte-Millán M, Ruiz-Borrego M, de la Haba J, Sánchez-Rovira P, Romero A, González-Neira A, Lluch A, Alba E. Santonja Á, et al. Among authors: de la haba j. Oncotarget. 2022 Jun 30;13:843-862. doi: 10.18632/oncotarget.28250. eCollection 2022. Oncotarget. 2022. PMID: 35782051 Free PMC article.
Electronic health records and patient registries in medical oncology departments in Spain.
Ribelles N, Alvarez-Lopez I, Arcusa A, Chacon JI, de la Haba J, García-Corbacho J, Garcia-Mata J, Jara C, Jerez JM, Lázaro-Quintela M, Leon-Mateos L, Ramirez-Merino N, Tibau A, Garcia-Palomo A. Ribelles N, et al. Among authors: de la haba j. Clin Transl Oncol. 2021 Oct;23(10):2099-2108. doi: 10.1007/s12094-021-02614-9. Epub 2021 Apr 17. Clin Transl Oncol. 2021. PMID: 33864619 Free PMC article.
35 results